Trials / Conditions / Grass Pollen Allergy

Grass Pollen Allergy

12 registered clinical trials studyying Grass Pollen Allergy — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	GRASS (Grass MATA MPL Real-world Assessment Study) NCT07412990	Allergy Therapeutics	—
Recruiting	Creating A Risk Assessment Tool for Thunderstorm Asthma: the CARISTA Study NCT07055542	University of Melbourne	N/A
Completed	A Motivation-enhancing App to Retain Patients With Hay Fever in a Trial After Treatment NCT05560698	University of Aarhus	N/A
Completed	Grass Pollen Immunotherapy Plus Dupilumab for Tolerance Induction NCT04502966	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 2
Completed	Diagnostic Accuracy of the MADx Multi Array Xplorer (MAX 45k) Automated Laboratory System and the MADx Allergy NCT04435678	MacroArray Diagnostics GmbH	N/A
Completed	Phase II Study of Grass Pollen Allergy Vaccine BM32 NCT01538979	Biomay AG	Phase 2
Completed	Regulatory T-cells After Subcutaneous Immunotherapy NCT01830673	Johann Wolfgang Goethe University Hospital	—
Completed	Safety and Dose Finding Trial of BM32 in Subjects Suffering From Grass Pollen Allergy NCT01445002	Biomay AG	Phase 2
Completed	Clinical Efficacy and Safety of gpASIT+TM to Treat Seasonal Allergic Rhinoconjunctivitis NCT01308021	BioTech Tools S.A.	Phase 2
Completed	A Phase III Trial Assessing the Pharmacodynamic Effect and the Tolerability of Grazax Treatment NCT00773240	ALK-Abelló A/S	Phase 3
Completed	Safety and Efficacy of a Sublingual Specific Immunotherapy With an Extract of a Six Grass Pollen Mixture NCT00264459	Allergopharma GmbH & Co. KG	Phase 3
Completed	Safety and Efficacy of Grass Pollen Allergoid in the Treatment of Allergic Rhinoconjunctivitis NCT00263601	Allergopharma GmbH & Co. KG	Phase 3